Abstract:Tanshinone IIA (Tan IIA), one of the major active constituents of the medicinal herb Salvia miltiorrhiza, has been reported to possess neuroprotective effects against the pathological features of Alzheimer's disease (AD), but the molecular mechanism underlying this effect remains unclear. To examine the effect of Tan IIA on AD, as well as the underlying molecular mechanisms, in vivo animal experiments and in vitro molecular biology investigations were employed in the present study. Firstly, a rat model of AD was successfully established by direct injection of the amyloid beta protein (A beta) and then these rats were administered an interventional treatment of Tan IIA. The learning and memory ability of rats was evaluated in four groups (Control, Sham, AD and Tan IIA) utilizing a Morris water maze test. Quantitative (q)PCR was employed to detect the mRNA expression of inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2) and nuclear transcription factor kappa (NF-kappa Bp65) in temporal lobe tissues and protein expression was determined with western blot analysis. In addition, association analyses between iNOS, MMP-2 and NF-kappa Bp65 at a transcriptional and translational level were performed utilizing Spearman's correlation analysis. In the present study, the results revealed that rats in the AD group demonstrated significant disruptions in learning and memory ability, and the symptoms were evidently reduced by Tan IIA. Furthermore, the upregulation of iNOS, MMP-2 and NF-kappa Bp65 at a transcriptional and translational level in AD rats was distinctly inhibited by Tan IIA. Therefore, it was concluded that iNOS, MMP-2 and NF-kappa Bp65 are involved in AD development, and Tan IIA may reduce AD risk by inhibiting transcription and translation of these genes. Furthermore, the positive correlation of iNOS and MMP-2 with NF-kappa Bp65, respectively, provides evidence supporting the hypothesis that Tan IIA reduces AD risk by inhibiting iNOS and MMP-2 at a transcriptional and translational level through the NF-kappa B pathway. In summary, Tan HA is an effective neuroprotective agent for AD therapy, and iNOS, MMP-2 and NF-kappa Bp65 may be the potential molecular targets for manipulating this effect therapeutically.

The Protective Effects of Tanshinone IIA on Neurotoxicity Induced by Β-Amyloid Protein Through Calpain and the P35/cdk5 Pathway in Primary Cortical Neurons.

The Protective Effects of TanIIA on Neurotoxicity Induced by Β-Amyloid Protein Through the Cdk5/P35 Pathway in Cultured Primary Neurons

The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons.

The Protective Effects of Tanshinone IIA on Β-Amyloid Protein (1–42)-Induced Cytotoxicity Via Activation of the Bcl-xL Pathway in Neuron

Shikonin Protects PC12 Cells Against β-amyloid Peptide-Induced Cell Injury Through Antioxidant and Antiapoptotic Activities

Tanshinone IIA attenuates Aβ-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-κB pathway in SH-SY5Y cells

Tanshinone IIA protects PC12 cells from β-amyloid-induced apoptosis via PI3K/Akt signaling pathway

Tanshinone IIA protects PC12 cells from β-amyloid 25–35 -induced apoptosis via PI3K/Akt signaling pathway

Tanshinone IIA protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway

Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro

Protective Effects of Tanshinone IIA on SH-SY5Y Cells Against Oaβ1–42-Induced Apoptosis Due to Prevention of Endoplasmic Reticulum Stress

[Effect of tanshinone IIA on the change of calcium current induced by beta-amyloid protein 25-35 in neurons of nucleus basalis of Meynert].

Tanshinone IIA Attenuates Aβ25–35‐induced Spatial Memory Impairment Via Upregulating Receptors for Activated C Kinase1 and Inhibiting Autophagy in Hippocampus

Tanshinone IIA Reduces the Risk of Alzheimer’s Disease by Inhibiting Inos, MMP-2 and NF-κBp65 Transcription and Translation in the Temporal Lobes of Rat Models of Alzheimer’s Disease

Effect of tanshinone IIA on the change of calcium current induced by β- Amyloid protein 25-35 in neurons of nucleus basalis of Meynert

Protection of Tanshinone ⅡA on cellular damage induced by glutamate and β-amyloid protein

Tanshinone IIA Regulates Glycogen Synthase Kinase-3Β-related Signaling Pathway and Ameliorates Memory Impairment in APP/PS1 Transgenic Mice.

[Effects of Tanshinone IIA on the Expressions of Caspase-3, Akt and NF-κB in the Brains of Rat Models of Alzheimer's Disease].

Tanshinone IIA improves Alzheimer’s disease via RNA nuclear-enriched abundant transcript 1/microRNA-291a-3p/member RAS oncogene family Rab22a axis

Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice

Tanshinone IIA Ameliorates Cognitive Deficits by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis in APP/PS1 Transgenic Mice